Wegovy Tracker: What to Track on Wegovy & How (2026)
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.
Quick answer
A Wegovy tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on semaglutide and why it matters.
Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist approved for chronic weight management.
It works slowly, over months, on a dose that climbs on a fixed calendar — which makes it exactly the kind of treatment that rewards good record-keeping.
This guide covers what to track on Wegovy, why each item matters clinically, and how to turn it into a two-minute weekly routine.
It is neutral and educational: you can do all of it on paper. An app just automates the parts people forget.
If you are weighing Wegovy against other GLP-1s or want the general framework first, start with our complete GLP-1 tracker app guide, then come back here for the Wegovy-specific details.
01
Why tracking matters on Wegovy specifically
Three things about Wegovy make tracking more than a nice-to-have:
The dose escalates on a schedule.
Wegovy starts low and steps up every four weeks. Logging which dose you took on which date keeps you synced to that plan and gives your prescriber an exact history at dose-adjustment visits.
It is once weekly, so a miss is easy.
A single skipped or late shot is far more likely with a weekly medicine than a daily one. A timestamped log makes the missed-dose decision simple instead of stressful (see the rule below).
Results and side effects are non-linear.
Weight comes off in fits and plateaus, and nausea tends to spike right after each dose increase. Only a trend — not a single day — tells you what is actually happening.
02
What to track on Wegovy (and why each one matters)
Here is the core Wegovy dataset. Use it as your checklist whether you track on paper, in a spreadsheet, or in an app.
Dose date and your Wegovy titration schedule
Wegovy is deliberately started low and increased every four weeks to reduce gastrointestinal side effects.
Per Novo Nordisk's dosing schedule, the standard escalation is 0.25 mg (weeks 1–4) → 0.5 mg (weeks 5–8) → 1 mg (weeks 9–12) → 1.7 mg (weeks 13–16) → 2.4 mg maintenance from week 17 onward (novoMEDLINK; FDA prescribing information).
Because the dose changes on a calendar, logging which mg you took on which date is the single most useful thing you can record.
Some patients may stay at 1.7 mg if 2.4 mg is not tolerated — your prescriber decides, and a clean dose log makes that conversation faster. 2.4 mg weekly is the standard maintenance dose.
A higher 7.2 mg weekly maintenance dose was approved in the EU (February 2026) and the US (March 2026, as Wegovy HD) for adults with obesity who have taken 2.4 mg for at least 4 weeks and need more weight loss; altered skin sensations (dysesthesia) were much more common at 7.2 mg (21.6% vs 0.3% on placebo in the STEP UP trial).
The missed-dose rule (worth getting right). Under the US FDA label, Wegovy uses a 2-day (48-hour) rule. Per Novo Nordisk: if your next scheduled dose is more than 2 days (48 hours) away, take the missed dose as soon as possible; if it is less than 2 days away, skip it and resume on your regular day.
If you miss two or more consecutive doses, your prescriber may have you re-start the escalation (novoMEDLINK).
A tracker that timestamps every shot turns this into a glance.
The US labels word Wegovy's and Ozempic's rules differently ("next dose more than 2 days away" vs "within 5 days of the missed dose"), but for a weekly shot they describe the same window.
This is the US FDA label wording.
The EU and many other countries' Wegovy leaflets say: take the missed dose within 5 days of the day you missed, otherwise skip it — check the leaflet in your own country and your prescriber.
Injection site and rotation
Wegovy is injected subcutaneously into one of three areas: the abdomen (keep at least two inches from the navel), the front of the thigh, or the upper arm, rotating each week (Novo Nordisk / wegovy.com).
Repeatedly injecting the same exact spot can cause lipohypertrophy — lumpy scar tissue that changes how the medicine is absorbed.
The problem is memory: after a few weeks, nobody recalls "left thigh or right arm last time?" This is where a tracker earns its keep — a good one shows a body map with your recent sites highlighted so you always pick a fresh one.
Weight, measurements, and progress photos
Weight is the headline number for a Wegovy weight loss tracker, but it is noisy day to day.
Weigh in at the same time (typically morning, after the bathroom, before eating) and let the trend line — not a single reading — tell the story.
Plateaus are common and medically explainable.
Waist measurements and progress photos every 2–4 weeks capture body-composition change the scale hides, which matters most exactly when the number stalls.
Protein, food, and protecting muscle
This is the most under-appreciated part of a Wegovy journey.
Because semaglutide sharply reduces appetite, a meaningful share of the weight you lose can be lean body mass — analyses of semaglutide trials such as STEP 1 have reported roughly 30–40% of lost weight as lean mass (the reported share varies widely between studies, and lean mass includes water and organ tissue, not only skeletal muscle) (Wilding et al., NEJM 2021 — STEP 1; Neeland et al., 2024).
Muscle protects your metabolism and long-term results. Two trackable habits do the heavy lifting:
- Protein. Aim for a high-protein target at each meal (many clinicians suggest distributing protein across the day). When appetite drops, protein is usually the first thing to fall — so logging it keeps it front of mind.
- Resistance training. Strength work, paired with adequate protein, is the main lifestyle defense against muscle loss on a GLP-1 (Codella et al., 2025); log your sessions like you log your dose.
Side effects — normal vs. red flag
The most common Wegovy side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, reflux, and reduced appetite.
These usually appear or worsen right after a dose increase and settle as your body adapts.
Rare but serious risks include pancreatitis and gallbladder disease, which need prompt medical assessment.
Logging what you felt, how severe, and how many days since your last dose or dose step-up turns a vague "I've felt off" into a clear pattern.
For the full symptom-by-symptom breakdown, see our guide to GLP-1 side effects.
Safety basics for any GLP-1 log. Don't use these medicines if you or a close relative has had medullary thyroid cancer, or if you have MEN 2.
They are not used during pregnancy — tell your prescriber right away if you become pregnant or plan to, because some must be stopped weeks to months beforehand.
If you also take insulin or a sulfonylurea, watch for low blood sugar (shakiness, sweating, confusion).
Vomiting or diarrhea that keeps you from holding down fluids can dehydrate you and strain your kidneys — call your clinician.
A tracker organizes your records; the package leaflet in your country and your prescriber come first.
| What to track | Why it matters | How often |
|---|---|---|
| Dose date & amount (mg) | Keeps you aligned with the titration schedule; confirms adherence; prevents accidental double-dosing | Every injection (weekly) |
| Injection site & rotation | Rotating sites prevents lumpy scar tissue (lipohypertrophy) that changes drug absorption | Every injection |
| Body weight | The primary outcome; the trend reveals plateaus and metabolic adaptation | 1–3× per week, same time of day |
| Waist / measurements | Catches fat loss the scale misses, especially while preserving muscle | Every 1–2 weeks |
| Protein intake (grams) | Protects lean muscle mass, which is at risk during rapid weight loss | Daily |
| Water / hydration | Eases the constipation and nausea common in the first weeks | Daily |
| Side effects & severity | Separates normal adaptation from red-flag symptoms needing a doctor | As they occur |
| Progress photos | Visual proof of body-composition change when the scale stalls | Every 2–4 weeks |
| Refill / pen supply | A weekly injectable runs out on a predictable date; avoids a coverage gap | Monthly |
03
How to build a Wegovy tracking routine in 6 steps
You do not need a complicated system — you need a repeatable one. This takes under two minutes a week for the core log, plus quick daily taps.
- 1
Set a weekly injection reminder.
Pick a consistent day and time and set a recurring alert so a late shot never sneaks up on you.
- 2
Log the dose and site right after injecting.
Record the mg amount and mark the body-map zone, so next week's rotation is obvious.
- 3
Weigh in on fixed days.
Choose 1–3 mornings a week, same conditions, and read the trend — not the daily noise.
- 4
Track protein and water daily.
A quick tap per meal is enough to keep muscle protection on track.
- 5
Note side effects when they happen.
Record the symptom, severity, and days since your last dose or dose increase.
- 6
Photo every 2–4 weeks and review before each visit.
Same lighting, same angle — and bring your dose log and side-effect timeline to your clinician.
04
Do you need a Wegovy app, or is a notebook fine?
Honestly, any tracking beats none — a Wegovy diary in a notebook works.
What an app adds is the automation of the parts people forget: the weekly reminder, the injection-site rotation map, the trend line that smooths daily weight noise, and a side-effect timeline you can hand to your clinician.
Wegovy does not ship with a dedicated companion app, so most people use a general GLP-1 or wellness tracker.
If you want your dose log living next to the daily habits that protect your results — protein, movement, hydration, weight and body-composition trends — a wellness app like HAVIT is a natural home for it.
Compare a few options in our best GLP-1 tracker apps guide and pick what you will actually keep using; consistency matters far more than the brand.
05
Related guides
06
Why HAVIT — Medication + Behavior Change, in One App
GLP-1 medications can meaningfully reduce weight — but the number on the scale is only part of the story.
Depending on the study, lean (non-fat) tissue has made up anywhere from about 15% to 40–60% of the weight lost on GLP-1–based therapy (Neeland et al., Diabetes, Obesity and Metabolism, 2024), and results tend to fade once the medication stops unless new habits take their place.
That's why leading guidance treats medication as one part of care, not the whole: the U.S. Preventive Services Task Force recommends that adults with obesity be offered intensive, multicomponent behavioral interventions (USPSTF, Grade B).
HAVIT is built for exactly this moment — one app that unites medication tracking, body composition, nutrition and protein, daily habit-building, and an AI coach that adapts to you.
Across our own 1,090 GLP-1 users, the most consistent trackers built the strongest habits (see the GLP-1 habit report).
Manage the medicine and the muscle — together. Start with HAVIT →
Frequently asked questions
What is a Wegovy tracker?
What should I track on Wegovy?
What is the Wegovy dose schedule I should log?
What happens if I miss a Wegovy dose?
Why do I need to track my Wegovy injection site?
How often should I weigh myself on Wegovy?
Why is protein tracking so important on Wegovy?
Is there an official Wegovy tracking app?
What is HAVIT?
HAVIT is an AI health partner built on metabolic science — it protects your muscle, wakes up your metabolism, and helps you keep a healthy, rebound-free body for the long run.
Unlike calorie-only trackers, HAVIT connects AI body-composition estimates, nutrition, hydration, sleep, steps, cycle, mood, and GLP-1 medication in one daily routine — so progress is measured by body composition, not just the number on the scale. Daily missions turn established behavior-change techniques into small repeatable actions, drawing on expertise from professionals formerly at Juvis Diet, one of Korea’s leading metabolic clinics.
In HAVIT’s own analysis of 1,090 GLP-1 users, people who logged consistently built stronger habits than the general user base. Read the GLP-1 Habit Report
Inside the app
- AI COACHA coach that reads your day.
- NUTRITIONLog meals in seconds.
- BODY INSIGHTSSee more than weight.
- DAILY MISSIONSBuild habits you can repeat.
- DAILY CHECK-INTell HAVI how today feels.
- TRACK EVERYTHINGFrom water to GLP-1
- MIND & RECOVERYFor the days willpower runs out.
HAVIT works with or without GLP-1 medication. It is a wellness app, not a medical device; body-composition results are estimates.
Continue in the App
Personalized wellness with your own data
References
- WEGOVY (semaglutide) injection — Full Prescribing Information accessdata.fda.gov
- Wegovy dosing and administration: dose escalation schedule and missed-dose guidance novomedlink.com
- Starting Wegovy: pen guide and injection sites wegovy.com
- Drug information portal (nedrug) — Wegovy approval information nedrug.mfds.go.kr
- Drug label (package insert) search platform — Wegovy approval information mcp.fda.gov.tw
- GLP-1 agonists: uses, how they work, and side effects my.clevelandclinic.org
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) doi.org
- Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies doi.org
- GLP-1 agonists and exercise: the future of lifestyle prioritization doi.org
- Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement doi.org
- FDA approves fourth product under National Priority Voucher program, higher dose semaglutide (Wegovy HD 7.2 mg), Mar 19, 2026 fda.gov
- Novo Nordisk — European Commission approves Wegovy 7.2 mg dose, Feb 17, 2026 biospace.com
- EMA — Wegovy EPAR product information (SmPC 4.2 missed dose, 4.6 breast-feeding) ema.europa.eu
